ArticleLeukemia research2019

Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia.

Daniel J DeAngelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.